Bancorp 34, Inc. (BCTF)

Theseus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	9.67	113.6	28.9	16.95	15.5	11.99
Investment Securities	213.54	90.42	33.97	31.16	34.03	27.46
Trading Asset Securities	-	0.36	-	-	-	-
Mortgage-Backed Securities	-	-	32.47	34.53	39.25	26.88
Total Investments	213.54	90.77	66.44	65.69	73.28	54.34
Gross Loans	676.61	676.09	457.03	464.73	417.03	354.63
Allowance for Loan Losses	-10.18	-10.16	-5.86	-4.78	-5.33	-4.82
Other Adjustments to Gross Loans	-	-	-	-1.37	-1.4	-1.06
Net Loans	666.43	665.93	451.17	458.58	410.3	348.74
Property, Plant & Equipment	11.98	12.48	9.17	10.14	8.39	9.25
Other Intangible Assets	7.18	7.59	-	-	-	0.1
Accrued Interest Receivable	2.57	2.61	1.6	1.51	1.35	1.66
Other Current Assets	-	4.02	4.27	4.95	2.94	1.29
Long-Term Deferred Tax Assets	-	9.03	4.88	4.92	3.1	2.11
Other Real Estate Owned & Foreclosed	-	-	3	-	-	-
Other Long-Term Assets	32.26	12.06	11.85	11.6	13.15	12.44
Total Assets	943.64	918.1	581.27	574.34	528.01	441.92
Interest Bearing Deposits	631.88	490.78	328.01	361.49	324.66	276.66
Institutional Deposits	-	83.2	43.9	23.4	13	17.6
Non-Interest Bearing Deposits	182.38	218.59	88.09	102.7	100.12	76.49
Total Deposits	814.26	792.57	460	487.59	437.78	370.75
Short-Term Borrowings	-	-	29	-	-	-
Current Portion of Long-Term Debt	-	-	-	5	-	-
Current Portion of Leases	-	1.08	0.25	-	-	-
Accrued Interest Payable	11.61	1.57	0.52	0.56	0.48	3.04
Long-Term Debt	27.72	27.35	24.6	24.53	24.45	-
Federal Home Loan Bank Debt, Long-Term	-	-	-	-	19	19
Long-Term Leases	-	3.54	1.76	2.15	0.47	1.03
Pension & Post-Retirement Benefits	-	1.93	2.01	1.95	0.17	-
Other Long-Term Liabilities	-	3.54	2.41	3.32	4.99	2.07
Total Liabilities	853.58	831.58	520.54	525.1	487.34	395.89
Preferred Stock, Convertible	-	-	-	0.01	-	-
Common Stock	0.08	0.08	0.05	0.03	0.03	0.03
Additional Paid-In Capital	67.53	67.32	43.28	28.37	14.65	22.81
Retained Earnings	28.3	25.99	24.3	29.01	28.38	24.32
Comprehensive Income & Other	-5.84	-6.87	-6.91	-8.18	-2.39	-1.13
Total Common Equity	90.06	86.52	60.72	49.23	40.67	46.03
Shareholders' Equity	90.06	86.52	60.72	49.24	40.67	46.03
Total Liabilities & Equity	943.64	918.1	581.27	574.34	528.01	441.92
Total Debt	27.72	31.97	55.61	31.68	43.92	20.03
Net Cash (Debt)	-18.05	81.98	-26.71	-14.74	-28.41	-8.05
Net Cash Per Share	-22.14	12.19	-6.63	-6.22	-10.44	-2.69
Filing Date Shares Outstanding	0.82	7.35	4.54	2.88	2.36	2.95
Total Common Shares Outstanding	0.82	7.35	4.54	2.88	2.36	2.95
Book Value Per Share	12.26	11.77	13.37	17.09	17.24	15.58
Tangible Book Value	82.87	78.93	60.72	49.23	40.67	45.94
Tangible Book Value Per Share	11.28	10.74	13.37	17.09	17.24	15.55

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.